Boston Scientific raised its annual profit forecast on Wednesday, after strong demand for its heart devices helped the U.S.

For the current quarter ending in September, Boston Scientific expects its per-share earnings to range from 70 cents to 72 cents. The company expects full-year earnings in the range of $2.95 to $2.99 ...

Understanding Analyst Ratings: A Comprehensive Breakdown The standing of Boston Scientific among financial experts is revealed through an in-depth exploration of recent analyst actions.

Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Boston Scientific ends global sales of ACURATE valves and halts FDA pursuit, citing rising regulatory burdens; expects to meet 2025 sales.

Edwards Lifesciences (EW) stock and Medtronic (MDT) stock gain as Boston Scientific (BSX) halts sales of ACURATE heart valves after regulatory feedback. Read more here.

Boston Scientific CEO Michael Mahoney's trust buys $17.25M mansion near North Palm Beach, continuing trend of Northeast execs buying luxury FL homes.

Shares of medical device company Boston Scientific (NYSE:BSX) jumped 8.5% in the pre-market session after the company reported first quarter 2025 results that beat analysts' sales and EPS ...

Marlborough medical device manufacturer Boston Scientific has entered into a purchase agreement worth up to half a billion dollars to acquire SoniVie, an Israel-headquartered medical device ...

Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making significant strides in recent years, positioning itself as a frontrunner in the ...